CDNS

Cadence Design Systems, Inc. - 10-Q Summary

Business Context and Reporting Period

This is a Quarterly Report (Form 10-Q) for Cadence Design Systems, Inc., covering the three and nine months ended September 27, 1997. The company provides electronic design automation (EDA) software and services. Key corporate events during the period included the merger with Cooper & Chyan Technology, Inc. (CCT) in May 1997 (accounted for as a pooling of interests) and the deconsolidation of Integrated Measurement Systems, Inc. (IMS) in February 1997, shifting its accounting treatment to the equity method. On October 19, 1997, the Board declared a two-for-one stock split.

Key Financial Metrics

Margins (Nine Months Ended Sep 27, 1997):

• Product Gross Margin: 91% (Cost of Product was 9% of revenue)
• Services Gross Margin: 29% (Cost of Services was 71% of revenue)
• Maintenance Gross Margin: 89% (Cost of Maintenance was 11% of revenue)
• Operating Margin: 23.7%

Material Changes vs. Prior Period

• Revenue Growth: Total revenue increased 24% for the quarter and 20% for the nine-month period compared to the prior year. Product revenue grew 32% (quarter) and 22% (nine months), driven by demand for custom IC and deep submicron design tools. Services revenue grew 31% (quarter) and 41% (nine months).
• Profitability: Net income increased 69% for the quarter and 39% for the nine-month period. Operating income rose 50% (quarter) and 14% (nine months).
• Unusual Items: The nine-month period included $34.1 million in unusual items, primarily related to the CCT merger ($16.0 million), restructuring of international operations ($6.4 million), and the write-off of in-process R&D from the Synthesia acquisition ($4.9 million).
• Comparability: Results are impacted by the deconsolidation of IMS (which contributed revenue in 1996 but not 1997) and the inclusion of CCT (acquired May 1997). Adjusted product revenue growth would have been 36% (quarter) and 29% (nine months) if IMS were excluded from 1996 and CCT included.
• Liquidity: Cash and short-term investments increased to $381.7 million from $285.5 million at the end of 1996. Working capital improved to $372.0 million.

Guidance, Outlook, Risks, and Contingencies

• Outlook: Management expects international revenues to remain a significant portion of total revenue. The company anticipates current cash balances and a $120 million revolving credit line will be sufficient for working capital and capital expenditure needs.
• Capital Expenditures: Anticipated additions to property, plant, and equipment for the remainder of 1997 are approximately $25.0 million. The company has committed to a $35.0 million venture capital partnership investment over the next 3-4 years.
• Legal Proceedings: Ongoing litigation with Avant! Corporation regarding trade secrets and copyright infringement. The Ninth Circuit Court of Appeals recently reversed a lower court decision, directing an injunction on the sale of Avant!'s ArcCell products. Management believes the resolution will not have a material adverse impact.
• Risks: Key risks include rapid technological changes in the EDA industry, integration risks from acquisitions (CCT, Synthesia), foreign currency fluctuations (notably the Japanese yen), and the potential for operating expenses to exceed revenue if market demand slows.
• Stock Split: A two-for-one stock split was declared on October 19, 1997, payable November 14, 1997. All per-share data in this filing has been retroactively adjusted.

Investor Verification Checklist

• Verify the impact of the IMS deconsolidation and CCT acquisition on year-over-year revenue and expense comparisons.
• Review the $34.1 million in unusual items to understand the non-recurring nature of the reported net income.
• Monitor the status of the Avant! litigation and the potential for injunctions or damages.
• Assess the company's exposure to foreign currency fluctuations, particularly the Japanese yen, which negatively impacted revenue by $8.0 million in the quarter.
• Confirm the execution of the two-for-one stock split and its effect on share count and liquidity.
• Track the utilization of the $120 million revolving credit line and the $35.0 million venture capital commitment.